Hospital Infection Control & Prevention – February 1, 2014
February 1, 2014
View Issues
-
CRE endoscope outbreak raises troubling questions about reprocessing, emerging New Delhi enzyme
An upper endoscopy procedure performed on some half million patients annually in the U.S. may pose risk for transmission of the emerging New Delhi variety of carbapenem-resistant Enterobacteriaceae (CRE) even if current cleaning and high level disinfection protocols are followed. -
OK, this may really be the stuff of nightmares
-
Hospital: No patient deaths linked to CRE outbreak
-
As CRE increases don't forget CDC toolkit
-
CDC still hopeful NDM threat can be contained
In a shrinking global village it seems a pathogen emerging anywhere is soon a threat everywhere, but public health officials are not conceding victory to the New Delhi metallo-β-lactamase (NDM) variety of carbapenem-resistant Enterobacteriaceae (CRE).